Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Merus N V | 3,525,000 | 3,525,000 | 0 | $185.41M | $331.88M | 16.20% | +$146.46M |
| Nuvalent Inc | 1,375,000 | 1,400,000 | +25,000 | $104.91M | $121.07M | 5.91% | +$16.16M |
| Xenon Pharmaceuticals Inc.(XENE) | 3,025,000 | 2,700,000 | -325,000 | $94.68M | $108.41M | 5.29% | +$13.72M |
| Cogent Biosciences, Inc.(COGT) | 2,311,164 | 7,250,000 | +4,938,836 | $16.59M | $104.11M | 5.08% | +$87.52M |
| Enliven Therapeutics Inc | 4,692,809 | 4,692,809 | 0 | $94.14M | $96.06M | 4.69% | +$1.92M |
| Agios Pharmaceuticals, Inc.(AGIO) | 2,325,000 | 2,338,287 | +13,287 | $77.33M | $93.86M | 4.58% | +$16.53M |
| Alkermes plcSHS(ALKS) | 2,450,000 | 3,096,754 | +646,754 | $70.09M | $92.90M | 4.54% | +$22.81M |
| Soleno Therapeutics Inc | 610,000 | 1,350,000 | +740,000 | $51.11M | $91.26M | 4.46% | +$40.15M |
| Relay Therapeutics, Inc.(RLAY) | 13,350,000 | 17,000,000 | +3,650,000 | $46.19M | $88.74M | 4.33% | +$42.55M |
| Celldex Therapeutics, Inc.(CLDX) | 3,450,000 | 3,028,335 | -421,665 | $70.21M | $78.34M | 3.82% | +$8.14M |
| Centessa Pharmaceuticals PlcADS | 3,298,289 | 2,850,000 | -448,289 | $43.34M | $69.11M | 3.37% | +$25.77M |
| Viridian Therapeutics, Inc.(VRDN) | 4,875,000 | 3,200,000 | -1,675,000 | $68.15M | $69.06M | 3.37% | +$903.5K |
| Protagonist Therapeutics Inc | 1,075,000 | 1,025,000 | -50,000 | $59.42M | $68.09M | 3.32% | +$8.68M |
| Pharvaris N V COM | 1,911,433 | 2,418,476 | +507,043 | $33.64M | $60.34M | 2.95% | +$26.70M |
| Cidara Therapeutics Inc | 1,175,000 | 585,000 | -590,000 | $57.23M | $56.02M | 2.73% | -$1.21M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 0 | 4,075,478 | +4,075,478 | $0 | $55.39M | 2.70% | +$55.39M |
| Tyra Biosciences, Inc.(TYRA) | 3,100,000 | 3,375,000 | +275,000 | $29.67M | $47.22M | 2.30% | +$17.55M |
| Terns Pharmaceuticals Inc | 0 | 5,700,000 | +5,700,000 | $0 | $42.81M | 2.09% | +$42.81M |
| Kymera Therapeutics, Inc.(KYMR) | 750,000 | 750,000 | 0 | $32.73M | $42.45M | 2.07% | +$9.72M |
| Mind Medicine Mindmed Inc | 5,000,000 | 3,225,000 | -1,775,000 | $32.45M | $38.02M | 1.86% | +$5.57M |
| Nurix Therapeutics, Inc.(NRIX) | 3,948,653 | 3,780,055 | -168,598 | $44.98M | $34.93M | 1.71% | -$10.05M |
| Oruka Therapeutics, Inc.(ORKA) | 1,419,714 | 1,753,054 | +333,340 | $15.91M | $33.71M | 1.65% | +$17.80M |
| Spyre Therapeutics, Inc.(SYRE) | 1,988,084 | 1,988,084 | 0 | $29.76M | $33.32M | 1.63% | +$3.56M |
| Bright Minds Biosciences Inc.(DRUG) | 500,000 | 500,000 | 0 | $13.05M | $30.33M | 1.48% | +$17.27M |
| Assembly Biosciences Inc | 0 | 1,000,000 | +1,000,000 | $0 | $25.60M | 1.25% | +$25.60M |
| CytomX Therapeutics, Inc.(CTMX) | 7,692,300 | 7,692,300 | 0 | $17.46M | $24.54M | 1.20% | +$7.08M |
| LB Pharmaceuticals Inc(LBRX) | 0 | 1,500,000 | +1,500,000 | $0 | $23.68M | 1.16% | +$23.68M |
| Tango Therapeutics, Inc.(TNGX) | 1,500,000 | 1,500,000 | 0 | $7.68M | $12.60M | 0.62% | +$4.92M |
| Apogee Therapeutics Inc | 290,000 | 290,000 | 0 | $12.59M | $11.52M | 0.56% | -$1.07M |
| PepGen Inc.(PEPG) | 0 | 2,357,319 | +2,357,319 | $0 | $10.89M | 0.53% | +$10.89M |
| Enanta Pharmaceuticals, Inc.(ENTA) | 0 | 800,000 | +800,000 | $0 | $9.58M | 0.47% | +$9.58M |
| SAB Biotherapeutics, Inc.(SABS) | 0 | 4,401,500 | +4,401,500 | $0 | $8.85M | 0.43% | +$8.85M |
| Inhibikase Therapeutics, Inc.(IKT) | 5,397,488 | 5,397,488 | 0 | $10.53M | $8.74M | 0.43% | -$1.78M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 750,000 | 750,000 | 0 | $7.96M | $7.92M | 0.39% | -$45.0K |
| Avalo Therapeutics, Inc.(AVTX) | 483,000 | 483,000 | 0 | $2.41M | $6.14M | 0.30% | +$3.73M |
| Vistagen Therapeutics, Inc.(VTGN) | 1,575,000 | 1,575,000 | 0 | $3.15M | $5.59M | 0.27% | +$2.44M |
| Crescent Biopharma, Inc.(CBIO) | 453,686 | 450,829 | -2,857 | $7.32M | $5.36M | 0.26% | -$1.96M |
| Neurogene Inc.(NGNE) | 427,866 | 0 | -427,866 | $6.40M | $0 | — | -$6.40M |
| Scholar Rock Holding Corporation(SRRK) | 1,450,000 | 0 | -1,450,000 | $51.36M | $0 | — | -$51.36M |
| Vera Therapeutics, Inc.CL A(VERA) | 800,000 | 0 | -800,000 | $18.85M | $0 | — | -$18.85M |